The Eczema Breakthroughs podcast features conversations between the world's leading eczema researchers and parents of children with eczema. Join the discussion by subscribing to the podcast through any of the below platforms:
|
|
|
Episode 8: Defining Eczema Types and Preparing for the Precision Medicine Revolution with Dr. Thomas Bieber.
How close are we to targeted treatments designed to each person with eczema? As parents, we often hear from people about a miracle approach that “cured” their or their child’s eczema, only to find that this same approach doesn’t work for us. We are continually reminded of the many different ways that eczema can appear and feel, and how people respond differently to different treatments. Right now, we have a largely “trial and error” approach to treating eczema but what will the future look like as we begin to understand eczema variation, sub-types, and personalized medicine? In this episode of the Eczema Breakthroughs podcast we chat with Professor Thomas Bieber who is chair and director of the department of dermatology and allergy at the University of Bonn in Germany. His cutting edge research focuses on biomarker discovery and precision medicine in allergic skin diseases and he was a speaker on the topic of risk stratification at the recent Revolutionizing Atopic Dermatitis global conference in April.
Research referenced in this episode:
Eczema types: Where are we and where should we go?
How close are we to targeted treatments designed to each person with eczema? As parents, we often hear from people about a miracle approach that “cured” their or their child’s eczema, only to find that this same approach doesn’t work for us. We are continually reminded of the many different ways that eczema can appear and feel, and how people respond differently to different treatments. Right now, we have a largely “trial and error” approach to treating eczema but what will the future look like as we begin to understand eczema variation, sub-types, and personalized medicine? In this episode of the Eczema Breakthroughs podcast we chat with Professor Thomas Bieber who is chair and director of the department of dermatology and allergy at the University of Bonn in Germany. His cutting edge research focuses on biomarker discovery and precision medicine in allergic skin diseases and he was a speaker on the topic of risk stratification at the recent Revolutionizing Atopic Dermatitis global conference in April.
Research referenced in this episode:
Eczema types: Where are we and where should we go?
Episode 7: In this episode, six parents of children with eczema from around the world share common experiences, challenges and silver linings from their eczema journeys, and dispel myths and misperceptions about the condition. Join us for this special edition of Eczema Breakthroughs recorded for World Atopic Eczema Day (#atopiceczemaday), which takes place annually on September 14th. Episode 7 is co-hosted with Keri Kelley.
Episode 6: What do the Iditarod and the immune system have in common? How can we harness the body’s defenses for fighting off infections and invaders to tackle eczema and its complications, including eczema herpeticum. Our guest for this episode of Eczema Breakthroughs is Dr. Brian Kim, Associate Professor of Medicine and Co-Director of the Center for the Study of Itch and Sensory Disorders at Washington University School of Medicine in St. Louis. His laboratory focuses on the immune mechanisms that underlie skin inflammation and the sensation of itch, and his groundbreaking translational research is showing new ways for addressing eczema by priming – rather than discouraging – the immune system. Episode 6 is co-hosted with Angela Tiru.
Research referenced in this episode: Revving up the immune system may help treat eczema
Research referenced in this episode: Revving up the immune system may help treat eczema
Episode 5: Dispatches from the frontlines of the "Battle of the Bacteria" with Dr. Richard Gallo
There’s a battle underway on the skin between bacteria that make eczema worse and bacteria that can improve symptoms. This fascinating discussion with Dr. Richard Gallo, Chairman of the Department of Dermatology at the University of California-San Diego, highlights his ground-breaking research approach which amplifies the presence of “good” bacteria in order to control domination of problematic strains, like Staph aureus. This bacterial "tinkering" is showing great promise against eczema. This podcast was recorded in 2018 as part of GPER’s research meetup series.
Research referenced in this podcast:
Eczema-associated bacteria may be kept in check by a different microbe
The microbiome in patients with atopic dermatitis
Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis
There’s a battle underway on the skin between bacteria that make eczema worse and bacteria that can improve symptoms. This fascinating discussion with Dr. Richard Gallo, Chairman of the Department of Dermatology at the University of California-San Diego, highlights his ground-breaking research approach which amplifies the presence of “good” bacteria in order to control domination of problematic strains, like Staph aureus. This bacterial "tinkering" is showing great promise against eczema. This podcast was recorded in 2018 as part of GPER’s research meetup series.
Research referenced in this podcast:
Eczema-associated bacteria may be kept in check by a different microbe
The microbiome in patients with atopic dermatitis
Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis
Episode 4: A Roadmap for Navigating the New Eczema Treatment Landscape with Dr. Eric Simpson
Almost every week we hear about new treatments for eczema, many with names that are hard to pronounce and even harder to remember. After a long drought, we’re suddenly experiencing a downpour in new options, but for parents and patients, it’s hard to navigate this evolving landscape. Dr. Eric Simpson, a dermatologist with OHSU and leading expert on new eczema treatments, walks us through what’s new, what’s coming, and how to make sense of it all.
Research referenced in this podcast:
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
Therapeutic Pipeline for Atopic Dermatitis: End of the Drought?
This podcast episode was co-hosted by the Pediatric Dermatology Research Alliance (PeDRA), and produced in collaboration with the Revolutionizing Atopic Dermatitis Conference with support from Sanofi Genzyme and Regeneron.
Almost every week we hear about new treatments for eczema, many with names that are hard to pronounce and even harder to remember. After a long drought, we’re suddenly experiencing a downpour in new options, but for parents and patients, it’s hard to navigate this evolving landscape. Dr. Eric Simpson, a dermatologist with OHSU and leading expert on new eczema treatments, walks us through what’s new, what’s coming, and how to make sense of it all.
Research referenced in this podcast:
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
Therapeutic Pipeline for Atopic Dermatitis: End of the Drought?
This podcast episode was co-hosted by the Pediatric Dermatology Research Alliance (PeDRA), and produced in collaboration with the Revolutionizing Atopic Dermatitis Conference with support from Sanofi Genzyme and Regeneron.
Episode 3: A critical look at common treatment practices with Dr. Jonathan Silverberg
Oral and systemic steroids are used to treat eczema all the time, but are they safe and do they make sense for a long-term chronic disease? Antihistamines are the most commonly prescribed oral treatment for eczema, but do they actually address its symptoms and what are the risks of use in children? Dr. Jonathan Silverberg, a dermatologist and researcher with George Washington University, offers some straight talk in this episode of Eczema Breakthroughs. Tune in!
Research referenced in this podcast:
Comorbidities and the impact of atopic dermatitis
Use of systemic corticosteroids for atopic dermatitis
Increased ADHD symptoms in atopic dermatitis are associated with antihistamine use
A systemic review of the safety and efficacy of systemic steroids
This podcast episode was produced in collaboration with the Revolutionizing Atopic Dermatitis (RAD) Conference and with support from Sanofi Genzyme and Regeneron.
Oral and systemic steroids are used to treat eczema all the time, but are they safe and do they make sense for a long-term chronic disease? Antihistamines are the most commonly prescribed oral treatment for eczema, but do they actually address its symptoms and what are the risks of use in children? Dr. Jonathan Silverberg, a dermatologist and researcher with George Washington University, offers some straight talk in this episode of Eczema Breakthroughs. Tune in!
Research referenced in this podcast:
Comorbidities and the impact of atopic dermatitis
Use of systemic corticosteroids for atopic dermatitis
Increased ADHD symptoms in atopic dermatitis are associated with antihistamine use
A systemic review of the safety and efficacy of systemic steroids
This podcast episode was produced in collaboration with the Revolutionizing Atopic Dermatitis (RAD) Conference and with support from Sanofi Genzyme and Regeneron.
Episode 2: Messing with the Microbiome. A Conversation with Dr. Ian Myles
Why is eczema prevalence on the rise? Are chemicals found in many skin and cosmetic products to blame? How do we restore a healthy balance of bacteria on eczema-prone skin? Is eczema a genetic disease or is that a myth? Learn more by listening to this provocative chat with Dr. Ian Myles, a cutting-edge researcher with the NIH who studies "microbiome transplants" for the treatment of eczema.
Research referenced in this podcast:
First in-human microbiome transplant using Roseomonas mucosa bacteria
Is allergy a disease of dysbiosis?
Why is eczema prevalence on the rise? Are chemicals found in many skin and cosmetic products to blame? How do we restore a healthy balance of bacteria on eczema-prone skin? Is eczema a genetic disease or is that a myth? Learn more by listening to this provocative chat with Dr. Ian Myles, a cutting-edge researcher with the NIH who studies "microbiome transplants" for the treatment of eczema.
Research referenced in this podcast:
First in-human microbiome transplant using Roseomonas mucosa bacteria
Is allergy a disease of dysbiosis?
Episode 1: New ideas and ancient science -- A conversation with Dr. Peter Lio
Can you control itch with acupressure? Can toxins from bacteria complicate eczema? What is the Dr. Aron Regimen and what are we learning about it through research? Learn more in this interview with Dr. Peter Lio, a dermatologist and researcher with Northwestern University and the Chicago Integrative Eczema Center.
Research referenced in this podcast:
Acupressure Study
Review of alternative and complementary treatments for eczema
Case series study on CASM (Dr. Aron Regimen)
Review of the relationship between staph and eczema
Can you control itch with acupressure? Can toxins from bacteria complicate eczema? What is the Dr. Aron Regimen and what are we learning about it through research? Learn more in this interview with Dr. Peter Lio, a dermatologist and researcher with Northwestern University and the Chicago Integrative Eczema Center.
Research referenced in this podcast:
Acupressure Study
Review of alternative and complementary treatments for eczema
Case series study on CASM (Dr. Aron Regimen)
Review of the relationship between staph and eczema